Ingenio Device Algorithm Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.

Also called NCT01441583

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 139 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01441583
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, Belgium, Denmark, France, Germany, Hong Kong SAR China, Italy, Malaysia, Netherlands, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01441583. Randomized; single masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2012-06 (actual). Results posted on 2024-03-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ingenio Device Algorithm Study
Acronym
IVORY
Condition
Sinus Node Disease
Condition
AV Block
Condition
Heart Failure
Intervention (Device)
RAAT
Intervention (Device)
RYTHMIQ
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01441583
Content hash
f3d3ed5ec864d58fbe52c9f8e366a6ec3c1cfe953fa2b5e38426e3d4bd6d9a42